Creative Medical Technology Holdings, Inc. Interest and Other Income
Creative Medical Technology Holdings, Inc. (CELZ) reported Interest and Other Income of $50.91 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. interest and other income for the quarter ending 2026-06-30 was $50.91K, a 68.49% increase year-over-year.
- Creative Medical Technology Holdings, Inc. interest and other income for the quarter ending 2026-03-31 was $55.44K, a 147.69% increase year-over-year.
- Creative Medical Technology Holdings, Inc. interest and other income for the quarter ending 2025-06-30 was $30.22K, a 55.29% decline year-over-year.
- Creative Medical Technology Holdings, Inc. interest and other income for the quarter ending 2025-03-31 was $22.38K, a 72.57% decline year-over-year.
- Creative Medical Technology Holdings, Inc. interest and other income for fiscal 2025 was $147.81K, a 40.97% decline from fiscal 2024.
- Creative Medical Technology Holdings, Inc. interest and other income for fiscal 2024 was $250.38K, a 24.94% decline from fiscal 2023.
- Creative Medical Technology Holdings, Inc. interest and other income for fiscal 2023 was $333.56K, a 232.47% increase from fiscal 2022.
- Creative Medical Technology Holdings, Inc. interest and other income for fiscal 2022 was $100.33K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.91K 10-Q · filed 2026-08-07 | $106.35K 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $55.44K 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | $147.81K 10-K · filed 2026-03-20 | |||
| 2025-06-30 | $30.22K 10-Q · filed 2026-08-07 | $52.60K 10-Q · filed 2026-08-07 | $84.26K derived: sum of 3 quarters · filed 2026-08-07 | $153.80K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $22.38K 10-Q · filed 2026-05-08 | $54.04K derived: sum of 2 quarters · filed 2026-05-08 | $123.58K derived: sum of 3 quarters · filed 2026-05-08 | $191.16K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $31.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $101.20K derived: sum of 2 quarters · filed 2026-03-20 | $168.78K derived: sum of 3 quarters · filed 2026-03-20 | $250.38K 10-K · filed 2026-03-20 |
| 2024-09-30 | $69.54K 10-Q · filed 2024-11-08 | $137.12K derived: sum of 2 quarters · filed 2025-08-08 | $218.72K 10-Q · filed 2024-11-08 | $311.99K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | $67.58K 10-Q · filed 2025-08-08 | $149.18K 10-Q · filed 2025-08-08 | $242.45K derived: sum of 3 quarters · filed 2025-08-08 | $331.68K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $81.60K 10-Q · filed 2025-05-09 | $174.87K derived: sum of 2 quarters · filed 2025-05-09 | $264.10K derived: sum of 3 quarters · filed 2025-05-09 | $354.01K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $93.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $182.50K derived: sum of 2 quarters · filed 2025-03-14 | $272.41K derived: sum of 3 quarters · filed 2025-03-14 | $333.56K 10-K · filed 2025-03-14 |
| 2023-09-30 | $89.23K 10-Q · filed 2024-11-08 | $179.15K derived: sum of 2 quarters · filed 2024-11-08 | $240.29K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $89.91K 10-Q · filed 2024-08-09 | $151.06K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $61.20K 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $100.33K 10-K · filed 2024-03-22 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |